Blood cancer

Read More
Red blood cells (illustrative)

Israeli-American Gamida hits goal in phase 3 blood cancer trial

The company uses umbilical cord blood, which like bone marrow and peripheral blood, is a rich source of stem cells for transplantation.

Tel Aviv University researchers (from left): Dr. Yaron Carmi, Diana Rasuluniriana, Dr. Peleg Ride

Israeli blood cancer treatment could also kill solid tumors - new study

Lead researcher Dr. Yaron Carmi believes that the treatment will be available within two years for human trials and compassionate use.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy